Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
International Rectifier Corporation
International Rectifier's Board Unanimously Rejects Vishay's Unsolicited Revised Proposal
October 5th, 2008
The Board of Directors of International Rectifier Corporation (NYSE:IRF) announced that it has reviewed Vishay's unsolicited, revised proposal with the assistance of its financial and legal advisors (Goldman, Sachs & Co. and Fried, Frank, Harris, Shriver & Jacobson LLP, respectively) and unanimously determined that Vishay's $23 per share offer significantly undervalues the future prospects of the Company and is not in the best interests of International Rectifier and its stockholders. Richard J. Dahl, Chairman of the Board of International Rectifier said: "Vishay's offer still significantly undervalues the future prospects of the Company when compared to the value that...
Source: Pharma Investments, Ventures & Law Weekly (2008-10-05)
|
